Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
Viridian Therapeutics (VRDN) - Cash on Hand
Cash on Hand as of December 2023 : $0.47 B
According to Viridian Therapeutics's latest financial reports the company has $0.47 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Viridian Therapeutics - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.47 B | 12.44% |
| 2022-12-31 | $0.42 B | 115.55% |
| 2021-12-31 | $0.19 B | 54.31% |
| 2020-12-31 | $0.12 B | 375.47% |
| 2019-12-31 | $26.84 M | -57.03% |
| 2018-12-31 | $62.48 M | 31.7% |
| 2017-12-31 | $47.44 M | 1319.96% |
| 2016-12-31 | $3.34 M | -69.16% |
| 2015-12-31 | $10.83 M | 111.6% |
| 2014-12-31 | $5.11 M | 2349.28% |
| 2013-12-31 | $0.2 M | 85.72% |
| 2012-12-31 | $0.11 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -56.39% | 🇺🇸 USA |